Cargando…

Systemic Sclerosis 2011

Detalles Bibliográficos
Autores principales:	Chung, Lorinda, Distler, Oliver, Hummers, Laura, Krishnan, Eswar, Steen, Virginia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332200/ https://www.ncbi.nlm.nih.gov/pubmed/22577388 http://dx.doi.org/10.1155/2011/308231

Ejemplares similares

Vascular Disease in Systemic Sclerosis
por: Chung, Lorinda, et al.
Publicado: (2010)

Treatment of systemic sclerosis: is there any hope for the future?
por: Allanore, Yannick, et al.
Publicado: (2016)

Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study
por: Krishnan, Eswar, et al.
Publicado: (2011)

Digital Ischemic Loss in Systemic Sclerosis
por: Marvi, Umaima, et al.
Publicado: (2010)

Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
por: Linos, Eleni, et al.
Publicado: (2013)

Vascular alterations upon activation of TGFβ signaling in fibroblasts - implications for systemic sclerosis
por: Horn, Angelika, et al.
Publicado: (2010)

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
por: Bernstein, Elana J., et al.
Publicado: (2022)

Molecular targets for therapy in systemic sclerosis
por: Iwamoto, Naoki, et al.
Publicado: (2012)

Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension
por: Kolstad, Kathleen D., et al.
Publicado: (2022)

Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
por: Beyer, Christian, et al.
Publicado: (2009)

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography
por: Khanna, Dinesh, et al.
Publicado: (2022)

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
por: Arefiev, Kait, et al.
Publicado: (2011)

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
por: Seibold, James R, et al.
Publicado: (2020)

Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis
por: Domsic, Robyn T., et al.
Publicado: (2023)

Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
por: Ross, Laura, et al.
Publicado: (2023)

Haematopoietic stem cell transplantation in systemic sclerosis
por: Walker, Ulrich A, et al.
Publicado: (2018)

Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis
por: Liu, Qian, et al.
Publicado: (2020)

How does endothelial cell injury start? The role of endothelin in systemic sclerosis
por: Abraham, David, et al.
Publicado: (2007)

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis
por: Spiera, Robert, et al.
Publicado: (2020)

Cytokines in Systemic Lupus Erythematosus 2011
por: Poole, Brian D., et al.
Publicado: (2012)

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis
por: Koch, Alisa E, et al.
Publicado: (2007)

Optimal management of digital ulcers in systemic sclerosis
por: Abraham, Shawn, et al.
Publicado: (2015)

Author Correction: Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis
por: Liu, Qian, et al.
Publicado: (2020)

Nintedanib in Patients With Systemic Sclerosis–Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score
por: Kuwana, Masataka, et al.
Publicado: (2022)

Increased Mortality in Asians With Systemic Sclerosis in Northern California
por: Chung, Melody P., et al.
Publicado: (2020)

Tie2 as a novel key factor of microangiopathy in systemic sclerosis
por: Moritz, Falk, et al.
Publicado: (2017)

Calcineurin inhibitors in systemic sclerosis – a systematic literature review
por: Hofmann, Nina N., et al.
Publicado: (2022)

Patients with systemic sclerosis show phenotypic and functional defects in neutrophils
por: Impellizzieri, Daniela, et al.
Publicado: (2021)

The scientific basis for novel treatments of systemic sclerosis
por: Beyer, Christian, et al.
Publicado: (2009)

A broad look into the future of systemic sclerosis
por: Riemekasten, Gabriela, et al.
Publicado: (2022)

COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic
por: Denton, Christopher P, et al.
Publicado: (2020)

The journal's performance in 2011
por: Ruiz, Milton Artur
Publicado: (2011)

In the June 2011 issue
por: Nitrini, Ricardo
Publicado: (2011)

In the September 2011 issue
por: Nitrini, Ricardo
Publicado: (2011)

In the March 2011 issue
por: Nitrini, Ricardo
Publicado: (2011)

In the December 2011 issue
por: Nitrini, Ricardo
Publicado: (2011)

Readership survey 2011
por: Joshua, Elizabeth
Publicado: (2012)

A glance to 2011
por: Mortazavi, Vajihesadat
Publicado: (2012)

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis
por: Müller, Bettina, et al.
Publicado: (2020)

Innate immunity in systemic sclerosis
por: O’Reilly, S.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nc6prumaah6u78oksg3p6eca2k